Prof. Dr. Torsten Haferlach

Chief Executive Officer, MLL Münchner Leukämielabor

Prof. Torsten Haferlach spent the first part of his career as a medical doctor and hematologist at the university clinics in Kiel and Göttingen, then at the university clinic in Munich (LMU) where he acted as both the senior physician at the Department of Internal Medicine and the Head of the laboratory for leukemia diagnostics.

In 2005, he set up the Munich Leukemia Laboratory (www.mll.com) together with three colleagues from complementary disciplines. Today the lab processes over 125,000 blood or bone marrow samples per year, his practice treats more than 5,000 patients, and more than 750 articles have been published in top ranking, peer‐reviewed medical journals since the lab’s inception. Dr Haferlach is author or co-author of more than 690 peer-reviewed articles and also co-author of the new WHO Classification 2022.

The Munich Leukemia Laboratory (MLL) is a central reference laboratory providing diagnostic services for Germany and also for international studies in hematology. The MLL offers services 7 days a week, including cytomorphology, cytogenetics, FISH, immunophenotyping and molecular genetics, including also WGS and WTS.